1Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq
2Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, 19328, Jordan
3Department of Cosmetic Science, Pharmacological and Diagnostic Research Centre, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan
4Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, 11821, Jordan
5Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq
**Corresponding Author E-mail: a.alsamydai@ammanu.edu.jo
Online published on 10 June, 2024.
Dementia is a major health problem among the elderly around the world; the number of dementia patients, as well as antidementia drugs, has been increasing in recent years. In this paper, we searched the dementia treatment guidelines, domestic and foreign literature reports in the past five years, summarized the classification of dementia, the selection of current pharmacotherapies in dementia, evidence-based evaluation of guidelines and some drugs with clinical treatment prospects to provide a reference for the decision-making of dementia drug therapy.
Dementia, Guidelines, Antidementia Pharmacotherapies, Pharmaceutical care
